Novartis Investigative Site

Jönköping SE-551 85

0 studies enrolling now · 7 studies all time

What they study most

Acute Heart Failure, Advanced, Metastatic Breast Cancer, Breast Cancer, Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy, Neoplasms, Breast, Parkinson's Disease, Symptomatic Refractory Resistant Carcinoid Disease

Studies at this site

• Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer — Completed
• A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. — Completed
• Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis — Completed
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING
• Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease — Completed
• Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy — Completed